Glucuronic acid
WikiDoc Resources for Glucuronic acid |
Articles |
---|
Most recent articles on Glucuronic acid Most cited articles on Glucuronic acid |
Media |
Powerpoint slides on Glucuronic acid |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Glucuronic acid at Clinical Trials.gov Trial results on Glucuronic acid Clinical Trials on Glucuronic acid at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Glucuronic acid NICE Guidance on Glucuronic acid
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Glucuronic acid Discussion groups on Glucuronic acid Patient Handouts on Glucuronic acid Directions to Hospitals Treating Glucuronic acid Risk calculators and risk factors for Glucuronic acid
|
Healthcare Provider Resources |
Causes & Risk Factors for Glucuronic acid |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Glucuronic acid (from Greek γλυκερός - "sweet") is a carboxylic acid. Its structure is similar to that of glucose. However, glucuronic acid's sixth carbon is oxidized to a carboxylic acid. Its formula is C6H10O7.
The salts of glucuronic acid are known as glucuronates; the anion C6H9O7− is the glucuronate ion.
Glucuronic acid should not be confused with gluconic acid, a linear carboxylic acid resulting from the oxidation of a different carbon of glucose. Both Glucuronic Acid and Gluconic Acid are reported to be found in the fermented drink known as Kombucha. Glucuronic acid has been attributed with the mildly-alcoholic effect that drinking the tea has for some.
Functions
Glucuronidation
Glucuronic acid is highly soluble in water. In the animal body, glucuronic acid is often linked to substances such as drugs, pollutants, bilirubin, androgens, estrogens, mineralocorticoids, glucocorticoids, fatty acid derivatives, retinoids, and bile acids. These linkages involve O-glycosidic bonds, and this linkage process is known as glucuronidation.[1] Glucuronidation occurs mainly in the liver, although the enzyme responsible for its catalysis, UDP-glucuronyltransferase, has been found in all major body organs, e.g., heart, kidneys, adrenal gland, spleen, and thymus.[2] UDP-glucuronic acid (glucuronic acid linked via a glycosidic bond to uridine diphosphate) is an intermediate in the process and is formed in the liver.
The substances resulting from glucuronidation are known as glucuronides (or glucuronosides) and are typically much more water-soluble than the non-glucuronic acid-containing substance from which they were originally synthesised. The human body uses glucuronidation to make a large variety of substances more water-soluble, and, in this way, allow for their subsequent elimination from the body upon urination. Hormones may also be glucuronidated to allow for easier transport around the body. Pharmacists also commonly link drugs to glucuronic acid to allow for easier drug delivery.
Acyl glucuronidation
Acyl glucuronidation is an important metabolic pathway for fluoroquinolone antibiotics.
N-glucuronidation
Conformation
Unlike its C5 epimer iduronic acid, which may occur in a number of conformations, glucuronic acid occurs in predominantly the 4C1 conformation.[3]
Glucuronidases
Glucuronidases are those enzymes that hydrolyze the glycosidic bond between glucuronic acid and some other compound.
References
- ↑ King C, Rios G, Green M, Tephly T (2000). "UDP-glucuronosyltransferases". Curr. Drug Metab. 1 (2): 143–61. PMID 11465080.
- ↑ Bock K, Köhle C. "UDP-glucuronosyltransferase 1A6: structural, functional, and regulatory aspects". Methods enzymol. 400: 57–75. PMID 16399343.
- ↑ Ferro, D. R. Provasoli, A. (1990). "Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences". Carbohydr. Res. 195: 157–167. PMID 2331699.
Further reading
- Chiu SH, Huskey SW (1998). "Species differences in N-glucuronidation". Drug Metab. Dispos. 26 (9): 838–47. PMID 9733661.
- Kuehl GE, Murphy SE (2003). "N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP-glucuronosyltransferases". Drug Metab. Dispos. 31 (11): 1361–8. doi:10.1124/dmd.31.11.1361. PMID 14570768.
- Kuehl GE, Murphy SE (2003). "N-glucuronidation of trans-3'-hydroxycotinine by human liver microsomes". Chem. Res. Toxicol. 16 (12): 1502–6. doi:10.1021/tx034173o. PMID 14680362.
- Benowitz NL, Perez-Stable EJ, Fong I, Modin G, Herrera B, Jacob P (1999). "Ethnic differences in N-glucuronidation of nicotine and cotinine". J. Pharmacol. Exp. Ther. 291 (3): 1196–203. PMID 10565842.
- Mannfred A Hollinger, Introduction to Pharmacology, ISBN 0-415-28033-8
- Chang, K. M.; McManus, K.; Greene, J.; Byrd, G. D.; DeBethizy, J. D. Glucuronidation as a metabolic pathway for nicotine metabolism. 1991
- Coffman B.L., King C.D., Rios G.R. and Tephly T.R. The glucuronidation of opioids, other xenobiotics, and androgens by human
de:Glucuronidierung de:Glucuronsäure he:חומצה גלוקורונית sl:Glukuronska kislina Template:Jb1 Template:WH Template:WikiDoc Sources